157.07
Schlusskurs vom Vortag:
$159.93
Offen:
$158.6
24-Stunden-Volumen:
72,543
Relative Volume:
0.16
Marktkapitalisierung:
$4.43B
Einnahmen:
$802.80M
Nettoeinkommen (Verlust:
$53.51M
KGV:
90.79
EPS:
1.73
Netto-Cashflow:
$91.12M
1W Leistung:
+5.86%
1M Leistung:
-0.11%
6M Leistung:
-20.09%
1J Leistung:
-35.01%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Vergleichen Sie INSP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
INSP
Inspire Medical Systems Inc
|
157.06 | 4.43B | 802.80M | 53.51M | 91.12M | 1.73 |
![]()
ABT
Abbott Laboratories
|
129.69 | 228.46B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
102.03 | 146.31B | 17.55B | 2.03B | 2.37B | 1.37 |
![]()
SYK
Stryker Corp
|
369.30 | 132.87B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.14 | 107.41B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.57 | 41.35B | 5.54B | 4.18B | 259.90M | 7.00 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
2024-01-19 | Eingeleitet | Jefferies | Buy |
2024-01-02 | Herabstufung | Stifel | Buy → Hold |
2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
2023-04-14 | Eingeleitet | Mizuho | Buy |
2023-03-29 | Eingeleitet | UBS | Buy |
2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2022-04-13 | Eingeleitet | Truist | Buy |
2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
2020-09-22 | Eingeleitet | JP Morgan | Overweight |
2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
2020-07-15 | Eingeleitet | Goldman | Buy |
2020-06-18 | Bestätigt | Piper Sandler | Overweight |
2020-05-18 | Eingeleitet | Lake Street | Buy |
2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
2018-11-28 | Eingeleitet | Berenberg | Sell |
2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
2018-05-29 | Eingeleitet | Guggenheim | Buy |
2018-05-29 | Eingeleitet | Stifel | Buy |
2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Management to Share Strategic Updates at Major Healthcare ConferenceLive Webcast Available - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Inspire Medical hires top sleep medicine experts By Investing.com - Investing.com Canada
Inspire Medical (INSP) Strengthens Leadership with New Appointme - GuruFocus
Stifel Adjusts Inspire Medical (INSP) Price Target Amid Market Uncertainty | INSP Stock News - GuruFocus
Inspire Medical (INSP) Strengthens Leadership with New Appointments | INSP Stock News - GuruFocus
Inspire Medical hires top sleep medicine experts - Investing.com
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors - The Manila Times
Elite Sleep Medicine Experts Strengthen Inspire Medical's Leadership: Strategic Dual Appointment Signals Growth - Stock Titan
KeyBanc Adjusts Price Target for Inspire Medical (INSP) | INSP Stock News - GuruFocus
Commit To Buy Inspire Medical Systems At $125, Earn 18.1% Annualized Using Options - Nasdaq
(INSP) On The My Stocks Page - news.stocktradersdaily.com
Sleep Apnea Implants Market Expands in 2025 with Tech-Driven - openPR.com
Inspire Medical (INSP) Price Target Reduced by Mizuho Analyst | - GuruFocus
What Analysts Are Saying About Inspire Medical Systems Stock - Benzinga
Inspire Medical (INSP) Target Price Cut Ahead of Q1 Results | IN - GuruFocus
Inspire Medical (INSP) Target Price Cut Ahead of Q1 Results | INSP Stock News - GuruFocus
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
RBC Cuts Price Target on Inspire Medical Systems to $215 From $260, Keeps Outperform Rating - marketscreener.com
Inspire Medical Systems (NYSE:INSP) shareholder returns have been notable, earning 93% in 5 years - simplywall.st
Inspire Medical (INSP) Price Target Reduced by Truist Ahead of Q - GuruFocus
Truist Cuts Price Target on Inspire Medical Systems to $210 From $235, Keeps Buy Rating - MarketScreener
Medical Devices & SuppliesSpecialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest - Yahoo Finance
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & SuppliesSpecialty Segment - The Globe and Mail
SHAREHOLDER ALERT: Potential Recovery for Inspire Medical Systems, Inc. (INSP) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025 - The Manila Times
Inspire Medical Q1 2025 Earnings: Key Date and Conference Call Details Revealed - Stock Titan
How the (INSP) price action is used to our Advantage - news.stocktradersdaily.com
Inspire (INSP) Down 6.1% Since Last Earnings Report: Can It Rebound? - MSN
Investors Appear Satisfied With Inspire Medical Systems, Inc.'s (NYSE:INSP) Prospects - simplywall.st
Long Term Trading Analysis for (INSP) - news.stocktradersdaily.com
Inspire Medical Systems: Fine Company, Stretched Valuations And Slowing Growth - Seeking Alpha
Charles Schwab Investment Management Inc. Acquires 15,042 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
US Bancorp DE Purchases 820 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
Treating sleep apnea deemed important by US adults but 31% not receiving treatment - Healio
Jones Financial Companies Lllp Buys 210 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
Investors in Inspire Medical Systems (NYSE:INSP) have seen splendid returns of 248% over the past five years - Yahoo Finance
(INSP) Investment Report - Stock Traders Daily
Smartleaf Asset Management LLC Acquires 229 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by Mutual of America Capital Management LLC - Defense World
Inspire Medical Systems Inc (INSP) Insider Sell: John Rondoni Se - GuruFocus.com
Inspire Medical Systems, Inc. To Present At The Keybanc Capital Markets Healthcare Forum - MENAFN.COM
Inspire Medical Systems Inc (INSP) to Present at KeyBanc Capital Markets Healthcare Forum - GuruFocus.com
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum - The Manila Times
Inspire Medical Systems CTO John Rondoni sells $424,467 in stock - Investing.com
Inspire Medical Systems CTO John Rondoni sells $424,467 in stock By Investing.com - Investing.com UK
Earnings To Watch: Inspire Medical Systems Inc (INSP) Reports Q4 2024 Result - GuruFocus.com
Inspire Medical Systems, Inc. (NYSE:INSP) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Is Inspire Medical Systems, Inc. (INSP) the Best Medical Technology Stock to Buy According to Analysts? - Yahoo Finance
Hypoventilation Market Expected to rise, 2032 | ResMed, Fisher & Paykel Healthcare, Philips Respironics, Inspire Medical Systems, Eli Lilly, expected to drive market - Barchart
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by Truist Financial Corp - Defense World
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):